Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity
Authors:
Open Access
- 17 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 43 (5) , 1019-1031
Abstract
Purpose: There is a lack of data on post-HSCT non-osteopenic bone pathology specifically for children with inborn errors of immunity (IEI). We collected data on non-osteopenic bone pathology in children with IEI post-HSCT over two decades in a large tertiary pediatric immunology center. Methods: Descriptive study with data analysis of bone pathology in allo-HSCT for IEI was performed between 1/1/2000 to 31/12/2018 including patients alive at follow-up to July 2022. Records were analyzed for bone pathology and risk factors. Exclusion criteria included isolated reduced bone density, fractures, and skeletal anomalies due to underlying IEI and short stature without other bone pathology. Bone pathologies were divided into 5 categories: bone tumors; skeletal dysplasia; avascular necrosis; evolving bone deformities; slipped upper femoral epiphysis. Results: A total of 429 children received HSCT between 2000 and 2018; 340 are alive at last assessment. Non-osteopenic bone pathology was observed post-HSCT in 9.4% of patients (32/340, mean 7.8 years post-HSCT). Eleven patients (34%) had > 1 category of bone pathology. Seventeen patients (17/32; 53%) presented with bilateral bone pathology. The majority of patients received treosulfan-based conditioning (26/32; 81.2%). Totally, 65.6% (21/32) of patients had a history of prolonged steroid use (> 6 months). Pain was the presenting symptom in 66% of patients, and surgical intervention was required in 43.7%. The highest incidence of bone pathologies was seen in Wiskott-Aldrich syndrome (WAS) (n = 8/34; 23.5%) followed by hemophagocytic lymphohistiocytosis patients (n = 3/16; 18.8%). Conclusion: Non-osteopenic bone pathology in long-term survivors of allo-HSCT for IEI is not rare. Most patients did not present with complaints until at least 5 years post-HSCT highlighting the need for ongoing bone health assessment for patients with IEI. Children presenting with stunted growth and bone pathology post-HSCT should undergo skeletal survey to rule out development of post-HSCT skeletal dysplasia. Increased rates and complexity of bone pathology were seen amongst patients with Wiskott-Aldrich syndrome.Keywords
This publication has 36 references indexed in Scilit:
- Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-upExpert Review of Hematology, 2011
- Osteochondroma after Hematopoietic Stem Cell Transplantation in Childhood. An Italian Study on Behalf of the AIEOP-HSCT GroupTransplantation and Cellular Therapy, 2009
- Caring for cancer survivorsCancer, 2009
- Predictors of avascular necrosis of bone in long‐term survivors of hematopoietic cell transplantationCancer, 2009
- Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow TransplantationHaematologica, 2008
- Skeletal Complications After Bone Marrow Transplant in ChildhoodJournal of Pediatric Oncology Nursing, 2008
- Important role of corticosteroids in chronic granulomatous diseaseJournal of Medical Microbiology, 2007
- WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorptionBlood, 2004
- Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight casesBone Marrow Transplantation, 2002
- Wiskott-Aldrich syndrome associated with idiopathic infantile cortical hyperostosis (Caffey's disease).Archives of Disease in Childhood, 1973